نتائج البحث - Preetesh Jain
- يعرض 1 - 20 نتائج من 42
- اذهب إلى الاصفحة التالية
-
1
-
2
-
3
-
4
-
5
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations حسب Yuxuan Che, Yang Liu, Yixin Yao, Holly A. Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael Wang
منشور في 2023Artigo -
6
Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic Leukemia حسب Preetesh Jain, Michael J. Keating, William G. Wierda, Mariela Sivina, Philip A. Thompson, Alessandra Ferrajoli, Zeev Estrov, Hagop M. Kantarjian, Susan O’Brien, Jan A. Burger
منشور في 2016Artigo -
7
Long‐term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib حسب Preetesh Jain, Philip A. Thompson, Michael J. Keating, Zeev Estrov, Alessandra Ferrajoli, Nitin Jain, Hagop M. Kantarjian, Jan A. Burger, Susan O’Brien, William G. Wierda
منشور في 2017Artigo -
8
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia حسب Xiao‐Jie Yan, Igor Dozmorov, Wentian Li, Sophia Yancopoulos, Cristina Sison, Michael Centola, Preetesh Jain, Steven L. Allen, Jonathan E. Kolitz, R. Kanti, Nicholas Chiorazzi, Barbara Sherry
منشور في 2011Artigo -
9
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib حسب Preetesh Jain, Michael J. Keating, William G. Wierda, Zeev Estrov, Alessandra Ferrajoli, Nitin Jain, Binsah George, Danelle F. James, Hagop M. Kantarjian, Jan A. Burger, Susan O’Brien
منشور في 2015Artigo -
10
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells حسب Uri Rozovski, David Harris, Ping Li, Zhiming Liu, Preetesh Jain, Alessandra Ferrajoli, Jan A. Burger, Philip A. Thompson, Nitin Jain, William G. Wierda, Michael J. Keating, Zeev Estrov
منشور في 2018Artigo -
11
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials حسب Koji Sasaki, Sara S. Strom, Susan O’Brien, Elias Jabbour, Farhad Ravandi, Marina Konopleva, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Preetesh Jain, Sherry Pierce, Hagop M. Kantarjian, Jorge E. Cortés
منشور في 2015Artigo -
12
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy حسب Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Hun Ju Lee, Lucy Navsaria, Raphaël Steiner, Sairah Ahmed, Omar Moghrabi, Onyeka Oriabure, Wendy Chen, Maria Badillo, Christopher R. Flowers, Michael Wang
منشور في 2020Carta -
13
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study حسب Preetesh Jain, Hagop M. Kantarjian, Elias Jabbour, Graciela Nogueras González, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Evguenia Gachimova, Alessandra Ferrajoli, Steven M. Kornblau, Farhad Ravandi, Susan O’Brien, Jorge E. Cortés
منشور في 2015Artigo -
14
Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities حسب Preetesh Jain, Hagop M. Kantarjian, Aziz Nazha, Susan O’Brien, Elias Jabbour, Carlos G. Romo, Sherry Pierce, Marylou Cárdenas-Turanzas, Srđan Verstovšek, Gautam Borthakur, Farhad Ravandi, Alfonso Quintás‐Cardama, Jorge E. Cortés
منشور في 2013Artigo -
15
Four‐year follow‐up of a single arm, phase <scp>II</scp> clinical trial of ibrutinib with rituximab (<scp>IR</scp>) in patients with relapsed/refractory mantle cell lymphoma (<scp>... حسب Preetesh Jain, Jorge Romaguera, Samer A. Srour, Hun Ju Lee, Frederick Hagemeister, Jason R. Westin, Luis Fayad, Felipe Samaniego, Maria Badillo, Liang Zhang, L. Nastoupil, Rashmi Kanagal‐Shamanna, Nathan Fowler, Michael Wang
منشور في 2018Artigo -
16
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes حسب Ohad Benjamini, Preetesh Jain, Long Trinh, Wei Qiao, Sara S. Strom, Susan Lerner, Xuemei Wang, Jan A. Burger, Alessandra Ferrajoli, Hagop M. Kantarjian, Susan O’Brien, William G. Wierda, Zeev Estrov, Michael J. Keating
منشور في 2014Artigo -
17
Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid le... حسب Preetesh Jain, Hagop M. Kantarjian, Mona Lisa Alattar, Elias Jabbour, Koji Sasaki, Graciela Nogueras González, Sara Dellasala, Sherry Pierce, Srđan Verstovšek, William G. Wierda, Gautam Borthakur, Farhad Ravandi, Susan O’Brien, Jorge E. Cortés
منشور في 2015Artigo -
18
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells حسب Uri Rozovski, Srđana Grgurević, Carlos Bueso-Ramos, David Harris, Ping Li, Zhiming Liu, Ji Yuan Wu, Preetesh Jain, William G. Wierda, Jan A. Burger, Susan O’Brien, Nitin Jain, Alessandra Ferrajoli, Michael J. Keating, Zeev Estrov
منشور في 2015Artigo -
19
Long‐term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial حسب Dai Chihara, Hagop M. Kantarjian, Susan O’Brien, Jeffrey L. Jorgensen, Sherry Pierce, Stefan Faderl, Alessandra Ferrajoli, Rebecca Poku, Preetesh Jain, Philip A. Thompson, Mark Brandt, Rajyalakshmi Luthra, Jan A. Burger, Michael J. Keating, Farhad Ravandi
منشور في 2016Artigo -
20
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance حسب Preetesh Jain, Mohammad Javdan, Franziska Feger, Percy Chiu, C. Sison, Rajendra N. Damle, Tanzim Bhuiya, Filiz Şen, Lynne V. Abruzzo, Jan A. Burger, Andreas Rosenwald, Steven L. Allen, Jonathan E. Kolitz, Michael R. Kanost, Nicholas Chiorazzi, Barbara Sherry
منشور في 2011Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Oncology
Lymphoma
Leukemia
Chronic lymphocytic leukemia
Immunology
Cancer research
Gastroenterology
Mantle cell lymphoma
Biology
Cancer
Ibrutinib
Rituximab
Myeloid leukemia
Chemotherapy
Genetics
Imatinib
Immune system
Receptor
Surgery
Tyrosine kinase
Clinical trial
Dasatinib
Gene
Nilotinib
Physics
Biochemistry
Bruton's tyrosine kinase
Confidence interval